Oncology News and Research RSS Feed - Oncology News and Research Twitter

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.
EMQ to showcase healthcare and life sciences project at Arab Health

EMQ to showcase healthcare and life sciences project at Arab Health

Edgbaston Medical Quarter (EMQ) will be at Arab Health 2017 for the first time to showcase the healthcare and life sciences revolution taking place in the West Midlands, in the heart of the UK. [More]
Precision medicine advances diagnosis and treatment of children with brain tumors

Precision medicine advances diagnosis and treatment of children with brain tumors

Precision medicine - in which diagnosis and treatments are keyed to the genetic susceptibilities of individual cancers - has advanced to the point where it can now impact the care of a majority of children with brain tumors, a new study by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center suggests. [More]
MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

Use of an advanced form of the commonly used polymerase chain reaction (PCR) method to analyze circulating tumor cells (CTCs) may greatly increase the ability to diagnose early-stage cancer, increasing the likelihood of successful treatment. [More]
New study estimates overall prevalence of genital HPV infection among men in the U.S.

New study estimates overall prevalence of genital HPV infection among men in the U.S.

Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States, as well as a cause of various cancers, and a new study published online by JAMA Oncology estimates the overall prevalence of genital HPV infection in men ages 18 to 59. [More]
Northwestern Medicine investigators to lead clinical trial for people with rare cancers

Northwestern Medicine investigators to lead clinical trial for people with rare cancers

A novel national trial for people with no established alternative to treat their rare cancers is being co-led by Northwestern Medicine investigators, who helped conceive of and develop the project. [More]
Overall survival of advanced NSCLC patients receiving treatment better than untreated patients

Overall survival of advanced NSCLC patients receiving treatment better than untreated patients

Non-small cell lung cancer patients with advanced disease receiving standard of care treatment have a higher overall survival than similar patients not receiving treatment. [More]
ICLIO white paper spotlights top-level concerns in delivering immunotherapies for cancer

ICLIO white paper spotlights top-level concerns in delivering immunotherapies for cancer

While momentum around immunotherapies for cancer continues to build, the high cost of these therapies places them at the center of debate about how best to define and measure value in cancer care. [More]
‘Collateral lethality’ may create new therapeutic options for several cancers

‘Collateral lethality’ may create new therapeutic options for several cancers

Cancer cells often delete genes that normally suppress tumor formation. These deletions also may extend to neighboring genes, an event known as "collateral lethality," which may create new options for development of therapies for several cancers. [More]
Researcher awarded $1.8 million grant to explore how chronic stress impacts cancer development

Researcher awarded $1.8 million grant to explore how chronic stress impacts cancer development

A five-year, $1.8 million grant (R01CA203965) from the National Cancer Institute awarded to Rutgers Cancer Institute of New Jersey resident research member Wenwei Hu, PhD, will support research to further elucidate the mechanisms behind the most frequently mutated gene in human tumors - p53. [More]
Biosimilars create chances to improve sustainability and affordability of cancer treatment

Biosimilars create chances to improve sustainability and affordability of cancer treatment

Biosimilars create opportunities for sustainable cancer care, says the European Society for Medical Oncology (ESMO) in a position paper published in ESMO Open. [More]
UT Southwestern researchers find cause and way to prevent vision deterioration in astronauts

UT Southwestern researchers find cause and way to prevent vision deterioration in astronauts

Vision deterioration in astronauts who spend a long time in space is likely due to the lack of a day-night cycle in intracranial pressure. But using a vacuum device to lower pressure for part of each day might prevent the problem, UT Southwestern Medical Center researchers said. Their study appears in the Journal of Physiology. [More]
Research findings could offer ways of fighting treatment resistance in oesophageal cancer

Research findings could offer ways of fighting treatment resistance in oesophageal cancer

Researchers at Trinity College Dublin have made exciting new findings that could offer a means of fighting resistance to treatment for people with oesophageal cancer. [More]
Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows

Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows

Researchers from the Genes and Cancer research group at the Bellvitge Biomedical Research Institute have identified inactivating mutations in a number of genes that code for HLA-I histocompatibility complex proteins, which are involved in the immune response and can condition the tesponse of lung cancer patients to immunotherapy. [More]
COGENT scientists uncover genes responsible for cognitive ability

COGENT scientists uncover genes responsible for cognitive ability

An international team of scientists, led by Todd Lencz, PhD, professor at The Feinstein Institute for Medical Research at Northwell Health and Hofstra Northwell School of Medicine, have unlocked some of the genes responsible for cognitive ability. [More]
Epigenetic changes drive successful metastases of pancreatic cancer cells

Epigenetic changes drive successful metastases of pancreatic cancer cells

A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells. [More]
Common drug for high blood pressure repurposed to treat soft tissue sarcoma in Europe

Common drug for high blood pressure repurposed to treat soft tissue sarcoma in Europe

A drug that's commonly used to treat high blood pressure is being repurposed for a rare tissue cancer in Europe. The medication, named propranolol, was recently granted Orphan Drug Designation by the European Commission. [More]
Ludwig study uncovers ancient cellular response that underlies spread of aggressive skin cancer

Ludwig study uncovers ancient cellular response that underlies spread of aggressive skin cancer

Each day, more than 1,600 people die from cancer in the US, and 450 in the UK, mostly because the disease has spread beyond a stage when surgery is an effective cure and has become resistant to therapy. Despite decades of research, understanding why cancer cells become invasive has remained shrouded in mystery. [More]
MGH researchers identify protein that may protect tumor-initiating cells in breast cancer

MGH researchers identify protein that may protect tumor-initiating cells in breast cancer

Massachusetts General Hospital investigators have identified a protein that may play an essential role in maintaining a population of tumor-initiating cells (TICs) -- treatment-resistant cells responsible for cancer recurrence and metastasis -- in breast cancer, as well as a compound that appears to reduce the molecule's ability to protect TICs from the effects of chemotherapy. [More]
Functional deficits caused by mini-strokes can last longer than previously thought

Functional deficits caused by mini-strokes can last longer than previously thought

Evidence overwhelmingly supports a link between cognitive decline and cerebrovascular diseases such as atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy. Not only do individuals with cerebrovascular diseases have a much higher incidence of cortical microinfarcts (mini-strokes), but post-mortem histological and in vivo radiological studies also find that the burden of microinfarcts is significantly greater among people with vascular cognitive impairment and dementia (VCID) than in age-matched, non-demented individuals. [More]
Yoga may help improve quality of life in pediatric cancer patients, study reveals

Yoga may help improve quality of life in pediatric cancer patients, study reveals

Quality of life of patients doing yoga improved, according to the conclusions of “Results of a Pilot Yoga Intervention to Improve Pediatric Cancer Patients’ Quality of Life and Physical Activity and Parents' Well-being”. [More]
Advertisement
Advertisement